DNA topoisomerases are enzymes involved in the relaxation of DNA during a number of critical cellular processes, including replication, recombination and transcription by transiently breaking one or two strands of DNA, passing a single-or double-stranded DNA through the break, and finally resealing the breaking.
DNA topoisomerases are enzymes involved in the relaxation of DNA during a number of critical cellular processes, including replication, recombination and transcription by transiently breaking one or two strands of DNA, passing a single-or double-stranded DNA through the break, and finally resealing the breaking. [1] [2] [3] Currently, only a camptothecin (CPT) family of compounds as DNA topoisomerase I-directed drugs has been introduced into the clinic to date, 4, 5) though many topoisomerase II-directed drugs have been in clinical use for many years. 6) DNA topoisomerases have been established as important molecular targets for anticancer drugs. 7) During our search for new DNA topoisomerase inhibitors from natural products by activity-guided fractionation, several solvent extracts of more than 100 Korean folk medicines were screened for their DNA topoisomerase I inhibitory activities. Among them, the CH 2 Cl 2 extract of the bark of M. thunbergii showed strong DNA topoisomerase I inhibitory activity (94.1% inhibition at 25 mg/ml), and was subjected to the isolation of compounds with DNA topoisomerase inhibitory activity from the CH 2 Cl 2 extract of the bark of M. thunbergii.
The bark of M. thunbergii has been used as a folk medicine for the treatment of leg oedema, abdominal pain and abdominal distension in Korea. 8) Lignans, [8] [9] [10] [11] [12] alkaloids, 13) flavonoids, 14, 15) butanolides 16) and essential oils 17, 18) have been reported as components from M. thunbergii, some of which have hepatoprotective activity as antioxidants, 8) antibacterial activity 11, 19) and inhibitory activity on nitric oxide synthesis in activated macrophages. 16) In this study, we isolated ten lignans from the bark of the M. thunbergii, and investigated their DNA topoisomerases I and II inhibitory effects and cytotoxicity.
MATERIALS AND METHODS

General Procedures
Optical rotations were measured using a JASCO DIP-1000 (Tokyo, Japan) automatic digital polarimeter. The NMR spectra were recorded on a Bruker 250 MHz (DMX 250) spectrometer using Bruker's standard pulse program. Samples were dissolved in CDCl 3 -d 1 ing 31 fractions (F1-31). Fractions F4 (2.0 g) and F14 (5.0 g) were recrystallized with 100% MeOH to give compounds 1 (1.4 g) and 4 (3.2 g), respectively. The fractions F9 (500 mg) and F10 (600 mg) were rechromatographed on a reverse phase column (60ϫ2.0 cm, LiChroprep RP-18) with a MeOH-H 2 O (gradient from 30 to 100% MeOH) eluent, affording compounds 5 (30 mg) and 2 (16 mg), respectively. Fraction F13 (2.5 g) was rechromatographed on a reverse phase column (60ϫ3.0 cm, LiChroprep RP-18) with a MeOH-H 2 O (gradient from 10 to 100% MeOH) eluent, giving 19 subfractions (F13-1-F13-19). Subfractions F13-9 (680 mg) and F13-13 (100 mg) were chromatographed again on a reverse phase column (60ϫ2.0 cm, LiChroprep RP-18) with a MeOH-H 2 O (gradient from 30 to 100% MeOH) eluent, affording compounds 3 (30 mg), 6 (13 mg), 9 (24 mg) and 10 (9 mg), respectively. Fractions F16 (1.5 g) and F18 (700 mg) were rechromatographed on a reverse phase column (60ϫ2.0 cm, LiChroprep RP-18) with MeOH-H 2 O (gradient from 40 to 100% MeOH), affording compounds 7 (300 mg) and 8 (15 mg 
Assay for DNA Topoisomerase I Inhibition in Vitro
DNA topoisomerase I inhibition assay was carried out according to the method reported by Fukuda et al. 30) with minor modifications. DNA topoisomerase I activity was measured by measuring the relaxation of supercoiled pBR 322 plasmid DNA. The reaction mixture was comprised of 35 mM Tris-HCl (pH 8.0), 72 mM KCl, 5 mM MgCl 2 , 5 mM dithiothreitol, 2 mM spermidine, 0.01% bovine serum albumin (BSA), 250 ng pBR 322 plasmid DNA, and 0.3 U calf thymus DNA topoisomerase I. The reaction mixture was used for measuring the inhibition of DNA relaxation by the DNA topoisomerase I, in addition to a test compound solution (less than 0.25% DMSO) in a final volume of 10 ml. The reaction mixtures were incubated for 30 min at 37°C, and terminated by adding a dye solution comprising 2.5% SDS, 15% ficoll-400, 0.05% bromophenol blue, 0.05% xylene cyanole and 25 mM EDTA (pH 8.0). The reaction products were determined by electrophoresis on 1% agarose gel in TBE (Trisborate-EDTA) running buffer at 1.5 V/cm for 10 h. The gels were stained with ethidium bromide (0.5 mg/ml) for 30 min, then destained in water for 30 min. For visualization and quantitative analyses of the DNA topoisomerase I activity, the gels were directly scanned with an image analyzer, and the area representing supercoiled DNA was calculated.
Assay for DNA Topoisomerase II Inhibition in Vitro DNA topoisomerase II activity was measured by assessing relaxation of supercoiled pBR 322 plasmid DNA. The reaction mixtures contained 50 mM Tris-HCl (pH 8), 120 mM KCl, 10 mM MgCl 2 , 0.5 mM ATP, 0.5 mM dithiothreitol, 300 ng pBR 322 plasmid DNA, 0.3 U human DNA topoisomerase II, and the indicated compound concentrations (less than 0.25% DMSO), in a final volume of 20 ml. The reaction mixtures were incubated for 30 min at 37°C, and terminated by the addition of 5 ml of a mixture containing 0.77% SDS, 77 mM EDTA (pH 8.0), 30% sucrose, 0.5% bromophenol blue and 0.5% xylene cyanole. The reaction products were determined by electrophoresis on 1% agarose gel in TBE (Tris-borate-EDTA) running buffer, at 1.5 V/cm for 10 h. The gels were stained with 0.5 mg/ml ethidium bromide for 30 min and destained in water for 30 min. For visualization and quantitative analyses of DNA topoisomerase II activity, the gels were directly scanned with an image analyzer, and the area representing supercoiled DNA was calculated.
Cytotoxicity Assay A tetrazolum-based colorimetric assay (MTT assay) was used to determine the cytotoxicity towards human colon carcinoma (HT-29) and human breast carcinoma (MCF-7) cell lines. 31) 
RESULTS AND DISCUSSION
The methanol extract of the bark of M. thunbergii was partitioned by solubility to a different solvent, giving methylene chloride, ethyl acetate and water extracts. Then, methylene chloride extract, which showed stronger inhibitory activity on topoisomerase I than the other extracts (Table 1) , was repeatedly subjected to both silica gel and reverse-phase gel to afford ten lignans (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . By comparison of their 1 H-and 13 C-NMR spectra, MS data, and optical rotation with reported values, their structures were characterized as machilin A (1), 9) erythro-austrobailignan-6 (2), 21, 22) meso-monomethyl dihydroguaiaretic acid (3), 23) meso-dihydroguaiaretic acid (4), 24) galbacin (5), 26) machilin F (6), 10) nectandrin A (7), 10, 27) nectandrin B (8), 10) (Ϫ)-acuminatin (9) 28) and (7S,8S)-7-(4-hydroxy-3-methoxyphenyl)-1Ј-formyl-3Ј-methoxy-8-methyldihydrobenzofuran (10) . 29) Among these lignans described, 2 and 10 were isolated for the first time from this Lauraceae family of the plant kingdom.
The conversions of supercoiled pBR 322 plasmid DNA to relaxed DNA by calf thymus topoisomerase I were examined in the presence of compounds 1-10, respectively. As shown in Table 2 , 2, 4 and 8 showed strong inhibition of supercoiled DNA relaxation induced by DNA topoisomerase I at a concentration of 100 mM, and when these three compounds were assayed at a concentration of 20 mM, 4 and 8 showed 38.8 and 41.3% inhibition, respectively. In DNA topoisomerase II assays, only compound 4 showed strong inhibition (84.1%) at a concentration of 100 mM ( Table 2 , Fig. 2 ) and 28.0% inhibi- Table 1 tion at a concentration of 20 mM.
To investigate whether these compounds (1-10) medicated the DNA topoisomerase inhibitory activity to induce cell death, these compounds were tested on human colon carcinoma and human breast carcinoma cell lines. As shown in Table 2 , compounds 1-5, 7, and 9 exhibited weak cytotoxicities against the HT-29 cell line: IC 50 values of 56.9, 37.3, 75.8, 45.4, 53.7, 84.9, and 54.5 mM, respectively; compounds 2-4 and 9 exhibited IC 50 values of 39.9, 94.5, 65.4, and 84.6 mM against the human breast carcinoma cell line (MCF-7).
At a concentration of 100 mM, 4 showed the strongest inhibitory activity on both DNA topoisomerases I and II and, as second and third effective inhibitors, 2 and 8 have selective inhibitory activity against DNA topoisomerase I activity compared to DNA topoisomerase II. However, these three compounds showed weak cytotoxicity against HT-29 and MCF-7 cell lines. These results indicate that no obvious correlation can be observed between the cytotoxicity of these compounds and the inhibitory activity of DNA relaxation and decatenation by DNA topoisomerases I and II. The reason the inhibition potencies of the above lignan compounds on the DNA topoisomerases I and II were not in parallel with the cytotoxicity might be that even though these compounds directly inhibit the reactions of DNA topoisomerases I or II in the enzyme assays in vitro, the transportation of these lignan compounds through cell and nuclear membranes, in order to reach the target DNA topoisomerases I and II, could be possible barriers in the MTT assay. These three compounds have a similar structural aspect to that of comptothecin, in which two benzene rings are connected by four carbon chain as, in comptothecin, three carbons and one nitrogen exist between the benzene and lactone rings of both ends of the molecule. In conclusion, 2, 4 and 8 were isolated as main topoisomerase I and II inhibitors from the bark of M. thunbergii, and showed weak cytotoxicity.
